POS0623 COMPARATIVE EFFECTIVENESS OF SUBCUTANEOUS SARILUMAB, SUBCUTANEOUS TOCILIZUMAB, AND INTRAVENO...
POS0623 COMPARATIVE EFFECTIVENESS OF SUBCUTANEOUS SARILUMAB, SUBCUTANEOUS TOCILIZUMAB, AND INTRAVENOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ANSWER COHORT STUDY
About this item
Full title
Author / Creator
Onishi, A. , Tanaka, M. , Onizawa, H. , Fujii, T. , Murata, K. , Murakami, K. , Hashimoto, M. , Watanabe, R. , Nozaki, Y. , Ashida, C. , Yamamoto, W. , Yamada, H. , Sendo, S. , Ebina, K. , Hidehiko, M. , Son, Y. , Wada, Y. , Hata, K. , Matsuda, S. and Morinobu, A.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Background:Targeting interleukin (IL)-6 has become a major therapeutic strategy and sarilumab (SAR) and tocilizumab (TCZ) are available in the treatment of rheumatoid arthritis (RA) [1]. Although SAR and TCZ have different forms of antibodies, dosages, routes, affinities to IL-6 receptors (IL-6R), and inhibition of IL-6/STAT3 signaling [2, 3], dire...
Alternative Titles
Full title
POS0623 COMPARATIVE EFFECTIVENESS OF SUBCUTANEOUS SARILUMAB, SUBCUTANEOUS TOCILIZUMAB, AND INTRAVENOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ANSWER COHORT STUDY
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3100857241
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100857241
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.1441
